How to Use Prenatal PHQ-9 and Antidepressant Course for Postpartum Risk
How can clinicians use the first prenatal PHQ-9 score and antidepressant continuation status to guide postpartum depression monitoring in pregnancy?
Clinicians often need to decide during pregnancy whether current depressive symptoms or medication changes meaningfully raise postpartum depression risk. This study provides concrete PHQ-9 categories and a medication-continuation signal that can help determine which patients need more intensive follow-up and shared decision-making.
-
Obtain the first PHQ-9 after the last menstrual period
Use the first documented prenatal PHQ-9 after the last menstrual period as the early pregnancy symptom measure. The health system in the study screened patients twice during pregnancy, and the first prenatal PHQ-9 was used to examine subsequent postpartum depression risk.
-
Classify prenatal depressive symptom severity by PHQ-9 range
Group PHQ-9 scores into the study's standard categories: less than 5, 5 to 9, 10 to 14, 15 to 19, and 20 to 27. These correspond to no depressive symptoms, mild, moderate, moderately severe, and severe depressive symptoms.
-
Interpret any PHQ-9 score of 5 or higher as increased postpartum risk
Do not dismiss mild symptoms as low consequence in this population. Compared with PHQ-9 less than 5, mild symptoms at 5 to 9 were associated with adjusted risk ratio 1.39 for any postpartum depression and 1.49 for severe postpartum depression.
-
Escalate concern as symptom severity rises
Risk increased across higher prenatal PHQ-9 categories. Moderate symptoms at 10 to 14 were associated with adjusted risk ratio 1.70 for any postpartum depression and 2.37 for severe postpartum depression, while moderate-severe symptoms at 15 to 19 were associated with adjusted risk ratio 1.92 for any postpartum depression and 3.58 for severe postpartum depression.
-
Review whether the antidepressant was continued or stopped during pregnancy
Assess pregnancy antidepressant status from medication fills during pregnancy, using the study's continued-versus-stopped framework with a 42-day permissible gap. Stopping an antidepressant during pregnancy was associated with higher adjusted risk of postpartum depression overall, with an adjusted risk ratio of 1.14, and of severe postpartum symptoms, with an adjusted risk ratio of 1.28.
-
Use PHQ-9 results and medication course in shared treatment planning
When prenatal symptoms are present or antidepressant discontinuation is being considered, discuss that both higher symptom burden and stopping medication were associated with greater postpartum depression risk in this cohort. The authors specifically note that this information can inform clinical decision-making and help connect patients early to depression care.
-
Plan postpartum surveillance through the first year
Maintain postpartum monitoring beyond the routine 6-week visit because the study defined postpartum depression using the highest PHQ-9 score and a depression ICD diagnosis from birth through 365 days after delivery. In this study, postpartum depression required both a PHQ-9 score of 10 or higher after delivery and a depression diagnosis.
Clinical Considerations
- The study shows association, not proof that changing antidepressant treatment or lowering prenatal PHQ-9 scores will reduce postpartum depression risk.
- Postpartum depression in the study was defined by both a postpartum PHQ-9 score of 10 or higher and a depression ICD diagnosis, which may differ from case definitions used in other settings.
- Although severe prenatal symptoms were associated with high postpartum risk, the reported risk estimates did not increase monotonically at every category because the severe 20 to 27 group had the same reported adjusted risk ratios as the moderate 10 to 14 group in the article text.
- This evidence comes from patients with recent depression diagnoses and adequate antidepressant treatment before pregnancy, so it should not be extrapolated directly to all pregnant patients.
Bottom Line
In pregnant patients with recent depressive episodes, even a first prenatal PHQ-9 score of 5 to 9 and any antidepressant discontinuation during pregnancy should trigger closer postpartum depression planning and follow-up.
